日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching

伊维菌素预防COVID-19:一项采用倾向评分匹配法对223,128名受试者进行的城市前瞻性观察研究

Kerr, Lucy; Cadegiani, Flavio A; Baldi, Fernando; Lobo, Raysildo B; Assagra, Washington Luiz O; Proença, Fernando Carlos; Kory, Pierre; Hibberd, Jennifer A; Chamie-Quintero, Juan J

Correction: Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching

更正:伊维菌素预防 COVID-19:一项采用倾向评分匹配法对 223,128 名受试者进行的城市范围前瞻性观察研究

Kerr, Lucy; Cadegiani, Flavio A; Baldi, Fernando; Lobo, Raysildo B; Assagra, Washington Luiz O; Proença, Fernando Carlos; Kory, Pierre; Hibberd, Jennifer A; Chamie-Quintero, Juan J

Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects

一项对88012名严格控制人群进行的前瞻性观察研究显示,规律使用伊维菌素预防COVID-19可使COVID-19死亡率降低高达92%,且呈剂量反应关系。

Kerr, Lucy; Baldi, Fernando; Lobo, Raysildo; Assagra, Washington Luiz; Proença, Fernando Carlos; Chamie, Juan J; Hibberd, Jennifer A; Kory, Pierre; Cadegiani, Flavio A

Catecholamines Are the Key Trigger of COVID-19 mRNA Vaccine-Induced Myocarditis: A Compelling Hypothesis Supported by Epidemiological, Anatomopathological, Molecular, and Physiological Findings

儿茶酚胺是新冠病毒mRNA疫苗诱发心肌炎的关键触发因素:流行病学、解剖病理学、分子生物学和生理学研究结果支持的有力假设

Cadegiani, Flavio A

Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial

普罗沙鲁胺显著加速病毒清除并缩短轻度至中度 COVID-19 患者达到临床缓解的时间:一项随机、双盲、安慰剂对照试验的结果

Cadegiani, Flavio A; McCoy, John; Gustavo Wambier, Carlos; Vaño-Galván, Sergio; Shapiro, Jerry; Tosti, Antonella; Zimerman, Ricardo A; Goren, Andy

Stay-At-Home Orders Are Associated With Emergence of Novel SARS-CoV-2 Variants

居家隔离令与新型SARS-CoV-2变种的出现有关

Zimerman, Ricardo A; Cadegiani, Flavio A; Pereira E Costa, Rute Alves; Goren, Andy; Campello de Souza, Bruno

The AndroCoV Clinical Scoring for COVID-19 Diagnosis: A Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1757-Patient Cohort

AndroCoV临床评分用于COVID-19诊断:一种基于1757例患者队列的快速、可行、低成本且高度敏感的COVID-19诊断工具

Cadegiani, Flavio A; Zimerman, Ricardo A; Campello de Souza, Bruno; McCoy, John; Pereira E Costa, Rute Alves; Gustavo Wambier, Carlos; Goren, Andy

Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial - Biochemical)

早期使用度他雄胺进行抗雄激素治疗可减少 COVID-19 男性患者的病毒脱落、炎症反应和缓解时间:一项随机、双盲、安慰剂对照干预试验(EAT-DUTA AndroCoV 试验 - 生化)

Cadegiani, Flavio A; McCoy, John; Gustavo Wambier, Carlos; Goren, Andy

Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial

普罗沙鲁胺治疗住院COVID-19患者的随机、安慰剂对照、双臂、平行临床试验的最终结果:Proxa-Rescue AndroCoV试验的多区域联合分析

Cadegiani, Flavio A; Zimerman, Ricardo A; Fonseca, Daniel N; Correia, Michael N; Muller, Marcio P; Bet, Diego Leonardo; Slaviero, Marcio Rafael; Zardo, Ivan; Benites, Paulo Roberto; Barros, Renan N; Paulain, Raysa W; Onety, Dirce C; Israel, Karla Cristina P; Gustavo Wambier, Carlos; Goren, Andy

Repurposing existing drugs for COVID-19: an endocrinology perspective

从内分泌学的角度探讨现有药物在新冠肺炎治疗中的应用

Cadegiani, Flavio A